Ключевые слова:
тромботические осложнения, коронарные сосуды, генетические, VEGF, фолатный цикл, антиоксидантной системы.Библиографические ссылки
Chinopoulos C. Succinate in ischemia: Where does it come from? //The international journal of biochemistry & cell biology. – 2019. – Т. 115. – С. 105580.
Consegal M. et al. Citric acid cycle metabolites predict infarct size in pigs submitted to transient coronary artery occlusion and treated with succinate dehydrogenase inhibitors or remote ischemic perconditioning //International journal of molecular sciences. – 2021. – Т. 22. – №. 8. – С. 4151.
Cubedo J. et al. Molecular signature of coronary stent thrombosis: oxidative stress and innate immunity cells //Thrombosis and Haemostasis. – 2017. – Т. 117. – №. 09. – С. 1816-1827.
El-Ghonaimy M. et al. Association of thrombophilic genes (MTHFR, MTR and MTRR) polymorphisms and homocysteine level in relation to the increased risk of thrombosis among COVID-19 patients //Gene Reports. – 2024. – Т. 37. – С. 102085.
Elykomov V. A., Nomokonova E. A., Efremushkina A. A. Thrombotic events and condition of thrombotic readiness in patients with ischemic heart disease //Bulletin of Medical Science. – 2018. – №. 3 (11). – С. 48-51.
He F., Zuo L. Redox roles of reactive oxygen species in cardiovascular diseases //International journal of molecular sciences. – 2015. – Т. 16. – №. 11. – С. 27770-27780.
Juni R. P. et al. Oxidative stress and pathological changes after coronary artery interventions //Journal of the American College of Cardiology. – 2013. – Т. 61. – №. 14. – С. 1471-1481.
Martin-Ventura J. L. et al. Oxidative stress in human atherothrombosis: sources, markers and therapeutic targets //International journal of molecular sciences. – 2017. – Т. 18. – №. 11. – С. 2315.
Moll S., Varga E. A. Homocysteine and MTHFR mutations //Circulation. – 2015. – Т. 132. – №. 1. – С. e6-e9.
Panicker B. T. et al. The association of hyperhomocysteinemia with acute post-operative complications following coronary artery bypass grafting //Asian Cardiovascular and Thoracic Annals. – 2023. – Т. 31. – №. 3. – С. 210-214.
Pantović S. et al. Markers of inflammation and antioxidant enzyme activities in restenosis following percutaneous coronary intervention //Journal of the Serbian Chemical Society. – 2015. – Т. 80. – №. 2. – С. 143-157.
Pereira A. C. et al. Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization //Thrombosis research. – 2007. – Т. 121. – №. 1. – С. 25-32.
Podemska-Jedrzejczak Z. et al. Vascular restenosis in coronary artery bypass grafting might be associated with VEGF-C/VEGFR-3 signaling pathway //Heart and Vessels. – 2018. – Т. 33. – №. 9. – С. 1106-1120.
Sarikaya S. et al. The role of genetics in coronary artery bypass surgery patients under 30 years of age //Cardiovascular Journal of Africa. – 2017. – Т. 28. – №. 2. – С. 77-80.
Singh P. R., Lele S. S. Folate gene polymorphisms MTR A2756G, MTRR A66G, and BHMT G742A and risk for coronary artery disease: a meta-analysis //Genetic testing and molecular biomarkers. – 2012. – Т. 16. – №. 6. – С. 471-475.
Timizheva K. B. et al. Association of the DNA methyltransferase and folate cycle enzymes’ gene polymorphisms with coronary restenosis //Life. – 2022. – Т. 12. – №. 2. – С. 245.
Valls-Lacalle L. et al. Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size //Scientific reports. – 2018. – Т. 8. – №. 1. – С. 2442.
Zinellu A., Mangoni A. A. A systematic review and meta-analysis of the effect of statins on glutathione peroxidase, superoxide dismutase, and catalase //Antioxidants. – 2021. – Т. 10. – №. 11. – С. 1841.